Back

Epigenetic age provides insight into tissue origin in endometriosis

Leap, K.; Yotova, I.; Horvath, S.; Martinez-Agosto, J. A.

2019-10-24 genetics
10.1101/815936 bioRxiv
Show abstract

BackgroundEndometriosis is a common reproductive disease with a heterogeneous presentation. Classification attempts have thus far not offered insight into its cause or its symptoms. Endometriosis may result from the migration of shed endometrium to the peritoneal cavity. However, there are cases reported in girls without uteruses and men. While a non-retrograde menstruation origin of ectopic tissue is certain in these cases, we propose using DNA methylation age (DNAm age) to distinguish between retrograde and non-retrograde etiologies.\n\nMethodsUsing publicly available DNA methylation data and Horvaths pan-tissue epigenetic clock, we compared DNAm age and epigenetic age acceleration (EAA) of ectopic lesions to eutopic endometrium of diseased and control endometrium. We examined EAA in cancer metastasis and teratomas to control for migration and developmental origin.\n\nResultsDisease status does not change DNAm age of eutopic endometrium, but the effect of ectopic status was profound: -16.88 years (p = 4.82 x 10-7). There were no differences between EAA of primary/metastatic tumor pairs, suggesting that the observed effect is not due to migration. Immature or mature teratoma compartments decreased DNAm age by 9.44 and 7.40 years respectively, suggesting that developmental state correlates with DNAm age.\n\nConclusionsEctopic endometriotic tissue exhibits decelerated DNAm age, similar to that observed in teratomas composed of multipotent tissue. The migration process does not change DNAm age and eutopic endometrium is concordant with chronological age regardless of disease status. We conclude that DNAm age of ectopic lesions can classify endometriosis into distinct subtypes that may be clinically relevant.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Human Reproduction
18 papers in training set
Top 0.1%
22.7%
2
Molecular Human Reproduction
11 papers in training set
Top 0.1%
10.2%
3
PLOS ONE
4510 papers in training set
Top 20%
9.2%
4
Scientific Reports
3102 papers in training set
Top 23%
4.9%
5
European Journal of Human Genetics
49 papers in training set
Top 0.2%
4.0%
50% of probability mass above
6
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 1%
4.0%
7
Journal of the Endocrine Society
11 papers in training set
Top 0.1%
3.6%
8
Clinical Epigenetics
53 papers in training set
Top 0.3%
2.8%
9
Journal of Medical Genetics
28 papers in training set
Top 0.2%
1.9%
10
Biology of Reproduction
28 papers in training set
Top 0.1%
1.8%
11
Frontiers in Medicine
113 papers in training set
Top 3%
1.7%
12
BMC Medicine
163 papers in training set
Top 3%
1.7%
13
Frontiers in Immunology
586 papers in training set
Top 5%
1.2%
14
Cancers
200 papers in training set
Top 4%
1.2%
15
International Journal of Molecular Sciences
453 papers in training set
Top 10%
1.2%
16
JCI Insight
241 papers in training set
Top 6%
0.9%
17
Endocrinology
38 papers in training set
Top 0.5%
0.9%
18
The Journal of Immunology
146 papers in training set
Top 1%
0.8%
19
Journal of Pathology Informatics
13 papers in training set
Top 0.3%
0.8%
20
Communications Biology
886 papers in training set
Top 21%
0.8%
21
BMC Pregnancy and Childbirth
20 papers in training set
Top 0.7%
0.8%
22
Sexually Transmitted Infections
21 papers in training set
Top 0.4%
0.8%
23
Frontiers in Genetics
197 papers in training set
Top 9%
0.8%
24
Bioinformatics
1061 papers in training set
Top 9%
0.8%
25
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 6%
0.8%
26
Frontiers in Endocrinology
53 papers in training set
Top 2%
0.8%
27
The FASEB Journal
175 papers in training set
Top 3%
0.8%
28
Biochemistry and Biophysics Reports
28 papers in training set
Top 2%
0.7%
29
Gene Reports
13 papers in training set
Top 0.7%
0.7%
30
Cells
232 papers in training set
Top 7%
0.7%